The selection of patients for targeted therapy is typically based on a series of diagnostic tests that identify specific genetic mutations or protein expressions in the cancer cells. These tests, often referred to as biomarker testing or genetic profiling, help oncologists determine whether a patientâs cancer is likely to respond to a particular targeted therapy. This personalized approach ensures that patients receive the most effective treatments based on their individual cancer profiles.
